Wave Life Sciences (WVE) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

Caris Life Sciences proprietary WES/WTS/WGS technology and massive data advantage underpin its leadership in oncology ...

The real issue is whether we can build a learning loop in which human expertise improves digital systems, and digital systems ...

Cassava Sciences (SAVA) said it will change its name to Filana Therapeutics, reflecting its focus on developing drugs that target the filamin A protein to treat central nervous system disorders. The ...

The U.S. life sciences industry is showing early signs of a sustained recovery, providing a potential catalyst for one of commercial real estate's most challenged sectors as renewed hiring and venture ...